The Return of Chikungunya in Bangladesh in 2024: Implications for Future Outbreaks
The American Journal of Tropical Medicine and Hygiene · 2025
DOI: 10.4269/ajtmh.25-0064 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2025. Verfasst von Anamul Hasan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Division, International Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh. Hauptthemen laut MEDLINE: Chikungunya Fever, Disease Outbreaks. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
After a major outbreak in Bangladesh in 2017, chikungunya nearly vanished from its territory until its resurgence in late 2024. However, its symptomatic overlap with dengue virus (DENV), another major arbovirus, has hindered accurate diagnosis and reporting, resulting in limited molecular diagnostic efforts for chikungunya in this region. This diagnostic evaluation study aimed to detect and characterize arboviral infections at the molecular level, focusing on the re-emergence of chikungunya and implications for future outbreaks. Febrile individuals aged 5–65 years old presenting with fever onset within 2–5 days along with other corresponding febrile symptoms were prospectively recruited from the International Centre for Diarrhoeal Disease Research, Bangladesh diagnostic facilities in Dhaka, Bangladesh. After meeting inclusion and exclusion criteria, 569 of 1,280 screened individuals were enrolled, providing informed written consent/assent. Serum samples from 474 participants underwent real-time reverse transcription-polymerase chain reaction testing, revealing 213 positive cases for at least one arbovirus. Chikungunya cases totaled 55, including seven coinfections (six with DENV and the first documented chikungunya virus–Zika virus coinfection in Bangladesh). No infections were reported from January to August, with a peak in October and November. Most chikungunya virus infections (72.7%) had moderate to high viral loads, with symptoms of joint pain, myalgia, and headaches. This resurgence of chikungunya in late 2024 highlights the potential for a major outbreak in 2025, necessitating proactive measures to mitigate public health impact and ensure a robust response to this re-emerging threat.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Infectious Diseases Division, International Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.
- Clinical and Diagnostic Services, International Centre for Diarrheal Disease Research, Bangladesh, Dhaka, Bangladesh.
Zitieren
APA
Hasan, A., Zamil, M. F., Trina, A. T., Hossain, M. S., Afreen, S., Ahmed, D., & Alam, M. S. (2025). The Return of Chikungunya in Bangladesh in 2024: Implications for Future Outbreaks. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.25-0064
Vancouver
Hasan A, Zamil MF, Trina AT, Hossain MS, Afreen S, Ahmed D, et al. The Return of Chikungunya in Bangladesh in 2024: Implications for Future Outbreaks. The American Journal of Tropical Medicine and Hygiene. 2025. doi:10.4269/ajtmh.25-0064
BibTeX
@article{Hasan2025,
author = {Hasan, Anamul and Zamil, Md Fahad and Trina, Afrida Tabassum and Hossain, Mohammad Sharif and Afreen, Sajia and Ahmed, Dilruba and Alam, Mohammad Shafiul},
title = {The Return of Chikungunya in Bangladesh in 2024: Implications for Future Outbreaks},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2025},
doi = {10.4269/ajtmh.25-0064}
}
EUVIMED